Electroconvulsive Therapy (ECT) is a medical treatment where small electric currents are passed through the brain to treat severe mental health issues. This study is looking at how ECT might help reduce severe agitation (extreme restlessness or aggression) in people with moderate to severe dementia conditions, including Alzheimer’s and other types. It will also check if the treatment is safe.

The study will involve 50 people and will run for 12 months. Participants will receive usual care along with ECT treatments. The study will monitor how well the treatment works and its safety over time.

• Participants must be 40 years or older and medically stable.
• The study requires an authorized representative to provide consent.
• Involves follow-up over a year with possible ECT treatments.

Only those who meet specific criteria, like having a certain level of agitation and a failed medication attempt, can join. People with other mental health conditions or recent ECT treatments cannot participate. This study aims to improve life quality for dementia patients by reducing agitation safely.